Access
To read this story in full you will need to login or make a payment (see right).
Insight
Nature 452, 548-552 (3 April 2008) | doi:10.1038/nature06913; Published online 2 April 2008
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Faculty Positions
- University of Texas Medical Branch
- Galveston, TX United States
Chair, Department of Informatic Medicine and Personalized Health
- University of Missouri-Kansas City
- Kansas City, Missouri, USA
Overview Article The cancer biomarker problem
Charles L. Sawyers1
Abstract
Genomic technologies offer the promise of a comprehensive understanding of cancer. These technologies are being used to characterize tumours at the molecular level, and several clinical successes have shown that such information can guide the design of drugs targeted to a relevant molecule. One of the main barriers to further progress is identifying the biological indicators, or biomarkers, of cancer that predict who will benefit from a particular targeted therapy.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
